The European Union has proposed the biggest drug overhaul in 20 years, prompting industry conflict; CMS has proposed 2 new rules focused on increasing care access and quality of care for people enrolled in Medicaid and the Children’s Health Insurance Program; proposed legislation would promise $6 billion for treatments of drug-resistant infections that win approval.